GlassScriptPhysician profile
Kara Suzanne Ornstein
NPI 1023181203
$1,514.98
in general payments reported to CMS, 2019-2025
19 companies · $214 in 2025
The $214 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $376 · 2021: $216 · 2022: $212 · 2023: $14.44 · 2024: $227 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $246.75 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $217.12 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $208.42 | 2019-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Pfizer INC. | $117.59 | 2022-2025 | |
| Sanofi Pasteur INC. | $109.46 | 2019-2025 | |
| Kaleo, INC. | $100.94 | 2019-2022 | |
| Cranial Technologies, INC | $81.49 | 2020-2022 | |
| Abbvie INC. | $57.13 | 2020-2023 | |
| Ars Pharmaceuticals Operations, INC. | $51.76 | 2025 | Neffy |
| Seqirus USA INC | $50.38 | 2021-2024 | Flucelvax |
| Sobi, INC | $40.58 | 2019 | |
| Collegium Pharmaceutical, INC. | $39.80 | 2025 | Jornay Pm |
| Kowa Pharmaceuticals America, INC. | $37.30 | 2025 | Zoryve |
| Covis Pharma Gmbh | $36.97 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $30.90 | 2024 | Qelbree |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $29.58 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.96 | 2020 | |
| Genentech USA, INC. | $17.98 | 2020 | |
| Phadia US INC. | $16.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Ornstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.